Evaluation of Cardiac, Autonomic Functions in Ambulant Patients with Duchenne Muscular Dystrophy

被引:2
作者
Amritharekha Nayak
Apoorva S B
Mainak Bardhan
R. Rashmi
G. Arunachal
P.V. Prathyusha
Atchayaram Nalini
T.N. Sathyaprabha
Kaviraja Udupa
机构
[1] National Institute of Mental Health And Neurosciences (NIMHANS),Department of Neurophysiology
[2] National Institute of Mental Health And Neurosciences (NIMHANS),Department of Neurology
[3] National Institute of Mental Health And Neurosciences (NIMHANS),Department of Human Genetics
[4] National Institute of Mental Health And Neurosciences (NIMHANS),Department of Biostatistics
关键词
Duchenne muscular dystrophy; Heart rate variability; Sinus tachycardia; Echocardiography;
D O I
10.1007/s42399-023-01473-5
中图分类号
学科分类号
摘要
Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder caused by dystrophin gene mutation resulting in muscle weakness, motor delays, difficulty in standing, and inability to walk by 12 years. As disease progresses, it leads to cardiac and respiratory failure. Evaluation of cardiac autonomic status and echocardiography in DMD patients at a young age can be a potential biomarker to assess disease progression. This study aimed to investigate the younger DMD population of 5–11years of age with mild to moderate cardiac involvement for early detection using non-invasive and cost-effective tools. Genetically confirmed male DMD patients, aged 5–11 years (n = 47), screened from the outpatient department of a tertiary neuroscience institution were subjected to heart rate variability and echocardiographic analysis, and values were correlated with their clinical variables. DMD patients showed a significantly higher difference in HR, interventricular septum, E m/s, and E-wave to A-wave (E/A) ratio than normal values (p < 0.001). Significantly higher HR indicates initial sinus tachycardia and decreased IVD (d), and increased E m/s and E/A ratio mark the onset of cardiac symptoms in DMD patients even though its chamber dimension remains normal and are associated with cardiac muscle fibrosis.
引用
收藏
相关论文
共 231 条
  • [1] Birnkrant DJ(2018)Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management Lancet Neurol 17 347-361
  • [2] Bushby K(2018)Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management Lancet Neurol 17 251-267
  • [3] Bann CM(2016)Dystrophin-deficient cardiomyopathy J Am Coll Cardiol 67 2533-2546
  • [4] Alman BA(1990)The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy Int J Cardiol 26 271-277
  • [5] Apkon SD(1998)X-Chromosomal (p21) Muscular dystrophy and left ventricular diastolic and systolic function Pediatr Cardiol 19 139-144
  • [6] Blackwell A(2018)Evaluation of early left ventricular dysfunction in patients with Duchenne muscular dystrophy using two-dimensional speckle tracking echocardiography and tissue Doppler imaging Pediatr Cardiol 39 1614-1619
  • [7] Birnkrant DJ(2004)Peak negative myocardial velocity gradient and wall-thickening velocity during early diastole are noninvasive parameters of left ventricular diastolic function in patients with Duchenne’s progressive muscular dystrophy J Am Soc Echocardiogr 17 322-329
  • [8] Bushby K(2007)Myocardial strain imaging for early detection of cardiac involvement in patients with Duchenne’s progressive muscular dystrophy Echocardiography. 24 598-608
  • [9] Bann CM(2016)The use of speckle tracking echocardiography for early detection of myocardial dysfunction in patients with Duchenne muscular dystrophy Pediatr Cardiol 37 1422-1428
  • [10] Apkon SD(2015)Feasibility and reproducibility of echocardiographic measures in children with muscular dystrophies J Am Soc Echocardiogr 28 999-1008